Another three truncating mutations in FANCC were observed in 438 breast cancer families, while 1 pathogenic mutation was identified in an additional 957 breast cancer families; no deleterious mutation was reported in 464 healthy controls nor in 1,000 genomic data (Thompson et al., 2012). This evidence concerns the gene FANCC and breast cancer.